menu search

SRBCF / Sirona Biochem stock climbs on anti-aging compound clinical trial results

Sirona Biochem stock climbs on anti-aging compound clinical trial results
Sirona Biochem (TSX-V:SBM) Corp shares surged 77% to $0.15 on Tuesday after the cosmetic ingredient and drug discovery company announced that clinical trial results for its novel anti-aging compound TFC-1326 have exceeded “even high expectations on key criteria.” Sirona said scientific results included a 37% increase in skin density along with a 25% improvement in skin radiance. Read More
Posted: Apr 25 2023, 11:40
Author Name: Proactive Investors
Views: 092163

SRBCF News  

Sirona Biochem to Present Ground-breaking Anti-Aging Technology at BIO 2023 Conference in Boston

By GlobeNewsWire
May 3, 2023

Sirona Biochem to Present Ground-breaking Anti-Aging Technology at BIO 2023 Conference in Boston

VANCOUVER, British Columbia, May 03, 2023 (GLOBE NEWSWIRE) -- Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (OTCQB: SRBCF) ("Sirona") is excited to ann more_horizontal

Sirona Biochem stock climbs on anti-aging compound clinical trial results

By Proactive Investors
April 25, 2023

Sirona Biochem stock climbs on anti-aging compound clinical trial results

Sirona Biochem (TSX-V:SBM) Corp shares surged 77% to $0.15 on Tuesday after the cosmetic ingredient and drug discovery company announced that clinic more_horizontal


Search within

Pages Search Results: